Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17 participants
OBSERVATIONAL
2007-12-31
2011-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodialysis-based Interventions to Preserve Cognitive Function
NCT02697942
Evaluation of the Effect of Cooled Haemodialysis on Cognitive Function in Patients Suffering With End-stage KD
NCT03645733
Interventions Made to Preserve Cognitive Function
NCT03616535
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
NCT00739843
Assessing Cognitive fUnction and MEasuring the Cerebral circulatioN on HaemoDialysis
NCT02393222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Prevalent patients who have been receiving more frequent dialysis.
Cognitive Function Testing-10 Tests
Trailmaking A, Trailmaking B, Rey Auditory Verbal Learning, Letter Number Sequencing, Digit Symbol Substitution, Grooved Pegboard, Controlled Oral Word Association, Beck Depression Index, Feeling Thermometer, Modified Mini-Mental Status
Sleep Assessment Testing
Sleep Assessment will be performed using an "Actiwatch" with subjects wearing the watch for 72 hours continuously
Periodic Leg Movement Syndrome Assessment
Subjects will wear and "Actiwatch" on both legs for three consecutive nights.
2
Incident patients new to more frequent dialysis
Cognitive Function Testing-10 Tests
Trailmaking A, Trailmaking B, Rey Auditory Verbal Learning, Letter Number Sequencing, Digit Symbol Substitution, Grooved Pegboard, Controlled Oral Word Association, Beck Depression Index, Feeling Thermometer, Modified Mini-Mental Status
Sleep Assessment Testing
Sleep Assessment will be performed using an "Actiwatch" with subjects wearing the watch for 72 hours continuously
Periodic Leg Movement Syndrome Assessment
Subjects will wear and "Actiwatch" on both legs for three consecutive nights.
3
Patients who switch from one more frequent hemodialysis treatment regimen to another more frequent dialysis regimen.
Cognitive Function Testing-10 Tests
Trailmaking A, Trailmaking B, Rey Auditory Verbal Learning, Letter Number Sequencing, Digit Symbol Substitution, Grooved Pegboard, Controlled Oral Word Association, Beck Depression Index, Feeling Thermometer, Modified Mini-Mental Status
Sleep Assessment Testing
Sleep Assessment will be performed using an "Actiwatch" with subjects wearing the watch for 72 hours continuously
Periodic Leg Movement Syndrome Assessment
Subjects will wear and "Actiwatch" on both legs for three consecutive nights.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Function Testing-10 Tests
Trailmaking A, Trailmaking B, Rey Auditory Verbal Learning, Letter Number Sequencing, Digit Symbol Substitution, Grooved Pegboard, Controlled Oral Word Association, Beck Depression Index, Feeling Thermometer, Modified Mini-Mental Status
Sleep Assessment Testing
Sleep Assessment will be performed using an "Actiwatch" with subjects wearing the watch for 72 hours continuously
Periodic Leg Movement Syndrome Assessment
Subjects will wear and "Actiwatch" on both legs for three consecutive nights.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or greater
* Ability to understand and a willingness to sign an informed consent statement and a Health Insurance Portability and Accountability Act of 1996 (HIPPA) authorization statement.
* Expected survival of at least one year.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Satellite Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte Schiller-Moran, MD
Role: PRINCIPAL_INVESTIGATOR
Satellite Healthcare, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Satellite Healthcare, Inc
Mountain View, California, United States
WellBound, Inc.
Mountain View, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SR016CF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.